Jan 25 (Reuters) - Valeant Pharmaceuticals (N:VRX) International
Inc's VRX.TO ailing chief executive, Michael Pearson (L:PSON), said he
was on the road to recovery but was uncertain about when he
would return from medical leave.
Valeant's VRX.N former chief financial officer, Howard
Schiller, is acting as interim chief executive.
Pearson was hospitalized with severe pneumonia in late
December.